VANCOUVER--(BUSINESS WIRE)--LifeSciences BC today announced the appointment of three new Board members representing leading life sciences companies in British Columbia. Mr. Ian Thompson, President, Canadian BioEnergy was appointed as of the September 16th Board of Directors’ meeting, and Dr. Steven Gillis, Managing Director, ARCH Venture Partners; and Mr. Gordon MacCauley, President & Chief Executive Officer, Allon Therapeutics were elected to LifeSciences BC’s Board of Directors at yesterday’s Annual General Meeting. Dr. Robert Sindelar of UBC was also re-elected to the Board of Directors.
